<!DOCTYPE html>
<html lang="zh-cn">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Official Site for KOKOWA®</title>
    <meta name="keywords" content="癌症,疫苗,WT1,日本,诺贝尔"/>
    <meta name="description" content="我们的WT1癌症疫苗,来自日本诺贝尔医学奖获得者。"/>
    <meta name="applicable-device" content="pc,mobile">
    <link href="css/bootstrap.css" rel="stylesheet">
    <link href="css/bxslider.css" rel="stylesheet">
    <link href="css/style.css" rel="stylesheet">
    <script src="js/jquery.min.js"></script>
    <script src="js/bxslider.min.js"></script>
    <script src="js/common.js"></script>
    <script src="js/bootstrap.js"></script>
    <!--[if lt IE 9]>
    <script src="js/html5shiv.min.js"></script>
    <script src="js/respond.min.js"></script>
    <![endif]-->

</head>
<body>

<header>
    <div class="topBox">
        <div class="borderBottom">
            <div class="container">
                <div class="row">
                    <div class="welcomeBox">KOKOWA<sup>®</sup></div>

                    <div class="languageBox">
                        <a href="javascript:;" class="zh">中文版</a>
                        <a href="javascript:;" class="en">English</a>
                        <a href="javascript:;" class="jp">日本語</a>
                    </div>
                    <!--div class="topContactBox">
                        <img src="images/tel.png" />
                        <a>400-400-400XX</a>
                        <img src="images/mail.png" />
                        <a>mxiangcai@163.com</a>
                    </div-->
                </div>
            </div>
        </div>

    </div>

    <!-- Fixed navbar -->
    <nav class="navbar navbar-default navbar-fixed-top">
        <div class="container">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar"
                        aria-expanded="false" aria-controls="navbar">
                    <span class="sr-only">Toggle navigation</span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
                <a href="index.html"><img src="images/logo1.png" class="logo" alt="欢迎光临~"/></a>

            </div>
            <div id="navbar" class="navbar-collapse collapse">
                <ul class="nav navbar-nav navbar-nav-c">
                    <li class="dropdown">
                        <a href="aboutWT1-cn.html">关于WT1</a>
                        <a href="javascript:;" id="app_menudown" class="dropdown-toggle" data-toggle="dropdown"
                           role="button" aria-expanded="false"><span
                                class="glyphicon glyphicon-menu-down btn-xs"></span></a>
                        <ul class="dropdown-menu nav_small" role="menu">
                            <li><a href="aboutWT1-cn-whatswt1.html">什么是WT1?</a></li>
                            <li><a href="vaccineAdaptedCancer-cn.html">WT1疫苗临床案例研究</a></li>
                            <li><a href="principleOfWT1-cn.html">WT1作为肿瘤抑制抗原的原理</a></li>
                        </ul>
                    </li>

                    <li class="dropdown">
                        <a href="kokowa-cn.html">关于KOKOWA<sup>®</sup>癌症疫苗</a>
                        <a href="javascript:;" id="app_menudown" class="dropdown-toggle" data-toggle="dropdown"
                           role="button" aria-expanded="false"><span
                                class="glyphicon glyphicon-menu-down btn-xs"></span></a>
                        <ul class="dropdown-menu nav_small" role="menu">
                            <li><a href="kokowa-cn.html">什么是KOKOWA<sup>®</sup>疫苗</a></li>
                            <li><a href="kokowaproduct-cn.html">KOKOWA<sup>®</sup>疫苗产品说明</a></li>
                        </ul>
                    </li>
                    <li class="dropdown">
                        <a href="javascript:;">我们该做些什么</a>
                        <a href="javascript:;" id="app_menudown" class="dropdown-toggle" data-toggle="dropdown"
                           role="button" aria-expanded="false"><span
                                class="glyphicon glyphicon-menu-down btn-xs"></span></a>
                        <ul class="dropdown-menu nav_small" role="menu">
                            <li><a href="">咨询您的保健医生</a></li>
                        </ul>
                    </li>
                    <li class="dropdown">
                        <a href="javascript:;">查询和支持</a>
                        <a href="javascript:;" id="app_menudown" class="dropdown-toggle" data-toggle="dropdown"
                           role="button" aria-expanded="false"><span
                                class="glyphicon glyphicon-menu-down btn-xs"></span></a>
                        <ul class="dropdown-menu nav_small" role="menu">
                            <li><a href="students.html">健康计划</a></li>
                            <li><a href="contact.html">援助计划</a></li>
                            <li><a href="contact.html">学术论坛</a></li>
                        </ul>
                    </li>

                </ul>
                -
            </div><!--/.nav-collapse -->
        </div>
    </nav>
</header>

<!-- bxslider -->
<div class="flash">
    <img src="images/kokowa-wt1-1.png" alt=""/>
</div>


<!--div class="page_bg" style="background: url(images/smal-banner-jp.png) center top no-repeat;">
</div-->

<div class="container threeImgBox">
    <div class="row">
        <div class="index_wt1">
            <h2>WT1疫苗的原理</h2>
            <span>WT1疫苗适应的癌症及临床案例。WT1的一段简要说明。</span>
            <ul>
                <li><a target=_blank href="javascript:;">疫苗的原理</a>
                    <a target=_blank href="javascript:;">基于肽的癌症疫苗原理</a>
                    <a target=_blank href="javascript:;">WT1肽基癌症疫苗的制备</a>
                </li>
                <!--<div class="detailContent"></div>-->
                <!--<div class="detailTime">2017/7/13 22:54:35</div>-->
            </ul>
        </div>0

    </div>
</div>
<!--div class="container" style="border-bottom:1px dashed #000;">
    <div class="col-xs-12 col-sm-8 col-md-7">
        <div class="news_box">
            <h2 class="title_h2">多发性骨髓瘤 </h2>

            <ul class="index_news">
                <p class="content">
                    骨髓瘤细胞对wt1特异性CTLs介导的颗粒胞吐途径高度敏感(79)。一位HLAA* 242
                    -阳性晚期耐药多发性骨髓瘤患者接受WT1疫苗治疗(图6和图7)(80)。接种WT1疫苗后，骨髓骨髓瘤细胞由85%下降至25%，尿中M蛋白含量由3.6 g/d下降至0.6
                    g/d。骨CT图显示骨病损的改善，特别是肋骨，因此临床反应被评估为最低限度(EGBMT标准)。
                </p>
            </ul>
        </div>
    </div>

    <div class="col-xs-12 col-sm-4 col-md-5">
        <div class="index_contact">
            <h2 class="title_h2"></h2>
            <ul class="index_news">
                <img src="images/kokowa-wt1-1.png" alt=""/>
            </ul>
        </div>
    </div>
</div-->

<div class="container" style="border-bottom:1px dashed #000;background:#ffe; filter: Alpha(Opacity=10, Style=0);">
    <div class="col-xs-12 col-sm-4 col-md-5">
        <div class="index_contact">
            <h2 class="left_h2">疫苗的原理 </h2>
            <ul class="index_news">
                <img src="images/cancerwork.jpg" alt="">
            </ul>
        </div>
    </div>

    <div class="col-xs-12 col-sm-8 col-md-7">
        <div class="contents">

            <ul class="index_news">
                <!--h2 class="left_h2"></h2-->
                <p class="content">
                    免疫系统的核心作用是通过区分自身和非自身细胞，并有效地保护个体免受微生物的侵害，其中许多微生物会导致疾病，并造成损害；免疫系统还可以保护我们免受癌症和毒素的侵害，以帮助维持我们的正常活动[1]。
                    癌细胞是具有异常生长潜力的自身细胞，由于几种基因突变而产生[2]。 一个多世纪以来科学家一直在研究如何让免疫系统可以控制癌症生长的想法。
                    Hanahan和Weinberg在2011年提出在癌症形成中有“逃避免疫系统”因素[2]。 我们临床上也遇到了从免疫监视中逃脱的癌细胞。
                    癌症免疫的一直在回答有关免疫系统如何参与癌症形成过程的问题[3]，以及免疫疗法是否能够消除已经过免疫逃逸的癌细胞。
                </p>
                <p>
                    1991年[4]Boon等人在黑色素瘤患者中鉴定第一种癌症抗原被描述为MAGE-A1的，开启了抗原特异性癌症免疫疗法的大门，这些免疫疗法来自免疫佐剂[5,6]和细胞因子等非特异性[7]。
                    在接下来的二十年中，已经鉴定出许多癌抗原，包括WT1，导致更有效的癌症免疫疗法的发展[8-10]。
                    目前，癌症免疫疗法预计是第四种最常见的癌症疗法，仅次于手术切除，放射疗法和化学疗法（包括分子靶向药物）。
                </p>

            </ul>
        </div>
    </div>

</div>

<div class="container">
    <div class="row">

        <!-- right -->
        <div class="col-xs-12 col-sm-8 col-md-9" style="float:right">
            <div class="list_box">
                <h2 class="left_h2">基于肽的癌症疫苗原理</h2>
                <div class="contents">
                    <p>
                        在大多数癌症免疫疗法中，关键过程涉及在体内或离体利用树突细胞（DC）的内在能力以诱导抗原特异性T细胞应答[13-15]。 基于肽的癌症疫苗简单且易于适应各种癌症患者，广泛用于临床试验。
                        基于肽的癌症疫苗的原理，其由HLA I类限制性组成肽和免疫佐剂如下（图1）[16,17]。

                    </p>
                    <p>
                        HLA I类限制性肽与一些免疫佐剂一起皮内或皮下注射。 肽与DC表面上的HLA I类分子结合，或被未成熟DC吸收并与HLA I类分子一起呈递在细胞表面上。
                        同时注射的免疫佐剂刺激未成熟的DCsin外周组织
                    </p>
                    <p>
                        这些活化的DC通过淋巴管转移至区域淋巴结，在那里它们作为完全成熟的DC到达，其表达抗原/ HLA-分子复合物和刺激抗原特异性T-淋巴细胞所必需的共刺激分子。
                    </p>

                    <p>抗原特异性T淋巴细胞，尤其是CD8 +细胞毒性T淋巴细胞（CTL）被成熟DC刺激增殖和分化，并形成有效细胞的克隆。
                    </p>
                    <p>
                        最终，抗原特异性CTL引发肿瘤床，并且在识别肿瘤细胞表面上的抗原后，通过诱导细胞凋亡并释放特异性细胞毒性颗粒（例如穿孔素和颗粒酶）来杀死靶向癌细胞。 </p>

                    <div>
                        <image src="./images/p8.png" class="contents_image"/>
                        <p class="contents_imageNote">图1基于肽的癌症疫苗的机制。</p>
                        <p class="contents_imageNote">
                            癌细胞表达宿主免疫系统识别的一些抗原，并在细胞表面上呈递源自该抗原/ HLA
                            I类复合物的肽。由基于肽的癌症疫苗引发的抗原特异性细胞毒性淋巴细胞通过T细胞受体（TCR）识别肽/ HLA I类复合物.</p>
                        <p class="contents_imageNote">
                            <p class="contents_sup">1</p>、Injection of cancer antigen and immune adjuvant 注射癌抗原和免疫佐剂   
                        </p>
                        <p class="contents_imageNote">
                        <p class="contents_sup">2</p>、Migration to lymph node and presentation of cancer antigen to T-cells; antigen-specifi c
                        cytotoxic T-lymphocytes ( CTLs ) 迁移至淋巴结并将癌抗原呈递至T细胞; 抗原特异性细胞毒性T淋巴细胞（CTLs）   
                        </p>
                        <p class="contents_imageNote">
                        <p class="contents_sup">3</p>、Proliferation and differentiation of T-lymphocytes T淋巴细胞的增殖和分化     
                        </p>
                        <p class="contents_imageNote">
                        <p class="contents_sup">4</p>、Cytotoxicity mediated by antigen-specifi c CTLs 由抗原特异性CTL介导的细胞毒性
                        </p>
                    </div>
                </div>
            </div>
            <div class="list_box">

                <h2 class="left_h2">WT1肽基癌症疫苗的制备</h2>
                <div class="contents">
                    <p>
                        基于肽的疫苗通常由肽和免疫佐剂组成。 肽可以进一步分为两组：HLA限制性短肽和非HLA限制性长肽[30]。 癌症免疫治疗靶向WT1的大多数临床研究使用了HLA限制性短肽基疫苗。
                    </p>
                    <p>
                        肽：使用HLA限制性短肽; 具体地，HLA-A * 24:02限制性修饰的9-mer WT1 235肽和/或HLA-A * 02:01限制性9-mer WT1 126肽。
                        肽的剂量通常为3毫克/体，尽管肽的推荐剂量（RD）尚未在剂量递增研究中确定[28,31]。
                    </p>
                    <p>
                        佐剂：免疫佐剂是增强免疫反应的物质。它们的功能大致可分为两类：（1）转运培养基，包括DC在内的抗原呈递细胞（APCs）有效地吞噬疫苗抗原;
                        （2）免疫调节剂。后者的角色是两者中更重要的角色。通过模式识别受体（PRR）激活DC，如Toll样受体（TLRs），是最重要的过程，对于启动先天免疫反应至关重要：这种信号传导使得不成熟的DC，其唯一的功能是捕获微生物和死细胞分化成成熟的DCs，可以处理并将其抗原呈递给区域淋巴结中的T淋巴细胞[33-35]。免疫佐剂的作用类似于病原体相关分子模式（PAMP）和损伤相关分子模式（DAMPs）以激活DC。
                    </p>
                    <p>
                        产品：我们描述了在我们的临床环境中经常使用的疫苗产品如下：将3mg WT1肽溶解在少量二甲基亚砜（DMSO）中，然后用5％葡萄糖将肽溶液稀释至400μl。最后，用等重量的Montanide
                        ISA51佐剂对混合物进行乳化[28]。
                    </p>
                </div>
            </div>
        </div>
        <!--div class="container" style="border-bottom:1px dashed #000;">
            <div class="col-xs-12 col-sm-8 col-md-7">
                <div class="news_box">
                    <h2 class="title_h2">多发性骨髓瘤 </h2>

                    <ul class="index_news">
                        <p class="content">
                            骨髓瘤细胞对wt1特异性CTLs介导的颗粒胞吐途径高度敏感(79)。一位HLAA* 242
                            -阳性晚期耐药多发性骨髓瘤患者接受WT1疫苗治疗(图6和图7)(80)。接种WT1疫苗后，骨髓骨髓瘤细胞由85%下降至25%，尿中M蛋白含量由3.6 g/d下降至0.6
                            g/d。骨CT图显示骨病损的改善，特别是肋骨，因此临床反应被评估为最低限度(EGBMT标准)。
                        </p>
                    </ul>
                </div>
            </div>

            <div class="col-xs-12 col-sm-4 col-md-5">
                <div class="index_contact">
                    <h2 class="title_h2"></h2>
                    <ul class="index_news">
                        <img src="images/kokowa-wt1-1.png" alt=""/>
                    </ul>
                </div>
            </div>
        </div-->

        <!-- left -->
        <div class="col-xs-12 col-sm-4 col-md-3">
            <div class="left_news">
                <h2 class="left_h2">相关研究和论文</h2>
                <ul class="index_news">
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            1. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome
                            11 Wilms tumor locus.
                        </a>
                        <span class='news_time'> Cell 1990;60:509–20.</span>
                        <span class='news_time'>Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            2. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome
                            jumping.
                        </a>
                        <span class='news_time'>Nature 1990;343:774– 8.</span>
                        <span class='news_time'>Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. </span>
                    </li>
                    <li>
                        <a href="https://link.springer.com/article/10.1007/BF02981935"
                           title="Wilms’ tumor gene WT1: its oncogenic function and clinical application.">
                            3. Wilms’ tumor gene WT1: its oncogenic function and clinical application.
                        </a>
                        <span class='news_time'>Int J Hematol 2001;73:177– 87.</span>
                        <span class='news_time'>Sugiyama H. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            4. Isolation, characterization, and expression of the murine Wilms tumor gene (WT1) during
                            kidney development.
                        </a>
                        <span class='news_time'>Mol Cell Biol 1991;11:1707– 12.</span>
                        <span class='news_time'>Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            5. The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a
                            human mesothelioma.
                        </a>
                        <span class='news_time'>Nature Genet 1993;4:415–20.</span>
                        <span class='news_time'>Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            6. Multiple roles for the Wilms’ tumor suppressor, WT1.
                        </a>
                        <span class='news_time'>Cancer Res 1999;59(Suppl 7):1747– 1750s; discussion 1751s.</span>
                        <span class='news_time'>Davies R, Moore A, Schedl A, Bratt E, Miyahawa K, Ladomery M, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            7. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal
                            gland and throughout nephrogenesis.
                        </a>
                        <span class='news_time'>Development 1999;126:1845–57.</span>
                        <span class='news_time'>Moore AW, Mclnnes L, Kreidberg J, Hastie ND, Schedl A.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            8. Expression of the Wilms tumor gene (WT1) in human leukemias.
                        </a>
                        <span class='news_time'>Leukemia 1992;6:405 –9.</span>
                        <span class='news_time'>Miwa H, Beran M, Aunders GF.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            9. Expression of the Candidate Wilms tumor gene, WT1, in human leukemia cells.
                        </a>
                        <span class='news_time'>Leukemia 1993;7:970 –7.</span>
                        <span class='news_time'>Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            10. WT1 as new prognostic factor a new marker for the detection of minimal residual disease
                            in acute leukemia.
                        </a>
                        <span class='news_time'>Blood 1994;84:3071–9.</span>
                        <span class='news_time'>Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            11. High levels of Wilms’ tumor gene (wt1) mRNA in acute myeloid leukemias are associated
                            with a worse long-term outcome.
                        </a>
                        <span class='news_time'>Blood 1997;90:1217– 25.</span>
                        <span class='news_time'>Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            12. The expression of the Wilms tumor gene in acute myelocytic leukemias as a possible
                            marker for leukemic blast cells.
                        </a>
                        <span class='news_time'>Leukemia 1994;8:2138–43.</span>
                        <span class='news_time'>Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            13. Presence of Wilms tumor gene (wt1) transcripts and the WT1 nuclear protein in the
                            majority of human acute leukemias.
                        </a>
                        <span class='news_time'>Leukemia 1995;9:1060–7.</span>
                        <span class='news_time'>Menssen HD, Renkl H-J, Rodeck U, Maurer J, Notter M, Schwartz S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            14. Detection by monoclonal antibodies of the Wilms’ tumor (WT1) nuclear protein in patients
                            with acute leukemia.
                        </a>
                        <span class='news_time'>Int J Cancer 1997;70:518–23.</span>
                        <span class='news_time'>Menssen HD, Renkl HJ, Rodeck U, Kari C, Schwartz S, Thiel E.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            15. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful
                            tool for monitoring minimal residual disease in acute leukemia patients.
                        </a>
                        <span class='news_time'>Leukemia 2002;16:2115– 21.</span>
                        <span class='news_time'>Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            16. Monitoring minimal residual disease in leukemia using real-time quantitative polymerase
                            chain reaction for Wilms tumor gene (WT1).
                        </a>
                        <span class='news_time'>Int J Hematol 2003;78:349– 56.</span>
                        <span class='news_time'>Tamaki H, Mishima M, Kawakami M, Tsuboi A, Kim EH, Hosen N, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            17. The usefulness of monitoring WT1 gene transcripts for the prediction and management of
                            relapse following allogeneic stem cell transplantation in acute type leukemia.
                        </a>
                        <span class='news_time'>Blood 2003;101:1698–704.</span>
                        <span class='news_time'>Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            18. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia
                            for the development of specific immunotherapies.
                        </a>
                        <span class='news_time'>Int J Cancer 2004;108:704– 11.</span>
                        <span class='news_time'>Greiner J, Ringhoffer M, Taniguchi M, Li L, Schmitt A, Shiku H, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            19.The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of
                            myelodysplastic syndromes.
                        </a>
                        <span class='news_time'>Leukemia 1999;13:393–9.</span>
                        <span class='news_time'>Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki J-H, Iwama H, Inoue K, et al.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            19.The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of
                            myelodysplastic syndromes.
                        </a>
                        <span class='news_time'>Leukemia 1999;13:393–9.</span>
                        <span class='news_time'>Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki J-H, Iwama H, Inoue K, et al.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            20.Expression of the Wilms’ tumor gene WT1 in solid tumors and its involvement in tumor cell
                            growth.
                        </a>
                        <span class='news_time'>Jpn J Cancer Res 1999;90:194– 204.</span>
                        <span class='news_time'>Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al.  </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            21.Overexpression of the Wilms’ tumor gene WT1 in primary astrocytic tumors.
                        </a>
                        <span class='news_time'>Cancer Sci 2004;95:822– 7.</span>
                        <span class='news_time'>Oji Y, Suzuki T, Nakano Y, Maruno M, Nakatsuka S, Jomgeow T, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            22.Overexpression of the Wilms’ tumor gene WT1 in head and neck squamous cell carcinoma.
                        </a>
                        <span class='news_time'>Cancer Sci 2003;94:523– 9.</span>
                        <span class='news_time'>Oji Y, Inohara H, Nakazawa M, Nakano Y, Akahani S, Nakatusuka S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            23.Overexpression of the Wilms’ tumor gene WT1 in primary thyroid cancer.
                        </a>
                        <span class='news_time'>Cancer Sci 2003;94:606–11.</span>
                        <span class='news_time'>Oji Y, Miyoshi Y, Koga S, Nakano Y, Ando A, Nakatuska S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            24.Overexpression of the Wilms’ tumor gene WT1 in esophageal cancer.
                        </a>
                        <span class='news_time'>Anticancer Res 2004;24:3103– 8.</span>
                        <span class='news_time'>Oji Y, Yano M, Nakano Y, Abeno S, Nakatsuka S, Ikeba A, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            25.Overexpression of the Wilms’ tumor gene WT1 in de novo lung cancers.
                        </a>
                        <span class='news_time'>Int J Cancer 2002;100:297– 303.</span>
                        <span class='news_time'>Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            26.Wilms’ tumor suppressor gene (WT1) is expressed in primary breast tumors despite
                            tumor-specific promoter methylation.
                        </a>
                        <span class='news_time'>Cancer Res 2001;61:921– 5.</span>
                        <span class='news_time'>Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            27.High expression of Wilms’ tumor suppressor gene (WT1) predicts poor prognosis in breast
                            cancer patients.
                        </a>
                        <span class='news_time'>Clin Cancer Res 2002;8:1167–71.</span>
                        <span class='news_time'>Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            28.Overexpression of the Wilms’ tumor gene WT1 in pancreatic ductal adenocarcinoma.
                        </a>
                        <span class='news_time'>Cancer Sci 2004;95:583–7.</span>
                        <span class='news_time'>Oji Y, Nakamori S, Fujikawa M, Nakatsuka S, Yokota A, Tatsumi N, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            29.Overexpression of the Wilms’ tumor gene WT1 in colorectal adenocarcinoma.
                        </a>
                        <span class='news_time'>Cancer Sci 2003;94:712–7.</span>
                        <span class='news_time'>Oji Y, Yamamoto H, Nomura M, Nakano Y, Ikeba A, Nakatsuka S, et al. </span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            30.Overexpression of the Wilms’ tumor gene WT1 in human bone soft-tissue sarcomas.
                        </a>
                        <span class='news_time'>Cancer Sci 2003;94:271– 6.</span>
                        <span class='news_time'>Ueda T, Oji Y, Naka N, Nakano Y, Takahashi E, Koga S, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            31.Absence of mutations in the Wilms’ tumor gene WT1 in primary breast cancer.
                        </a>
                        <span class='news_time'>Jpn J Clin Oncol 2004;34:74 –7.</span>
                        <span class='news_time'>Oji Y, Miyoshi Y, Kiyotoh E, Koga S, Nakano Y, Ando A, et al.</span>
                    </li>
                    <li>
                        <a href="http://www.honigyogyir.hu/konzultansaink/prof_dr_bertok_lorand"
                           title="Radio-detoxified endotoxin activates natural immunity: a review">
                            32.Absence of mutations in the Wilms’ tumor gene wt1 in de novo non-small cell lung cancers.
                        </a>
                        <span class='news_time'>Neoplasma 2004;51:17 –20.</span>
                        <span class='news_time'>Oji Y, Miyoshi S, Takahashi E, Koga S, Nakano Y, Shintani Y, et al.</span>
                    </li>

                </ul>
            </div>
        </div>

    </div>
</div>

<nav class="navbar navbar-default navbar-fixed-bottom footer_nav">
    <div class="foot_nav btn-group dropup">
        <a class="dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"
           href="javascript:;">
            <span class="glyphicon glyphicon-share btn-lg" aria-hidden="true"></span>
            分享</a>
        <div class="dropdown-menu webshare">
            <!-- JiaThis Button BEGIN -->
            <div class="jiathis_style_32x32">
                <a class="jiathis_button_qzone"></a>
                <a class="jiathis_button_tsina"></a>
                <a class="jiathis_button_tqq"></a>
                <a class="jiathis_button_weixin"></a>
                <a class="jiathis_button_renren"></a>
                <a href="javascript:;" class="jiathis jiathis_txt jtico jtico_jiathis" target="_blank"></a>
            </div>
            <script type="text/javascript" src="js/jia.js" charset="utf-8"></script>
            <!-- JiaThis Button END -->            </div>
    </div>
    <div class="foot_nav"><a href="javascript:;"><span class="glyphicon glyphicon-phone btn-lg"
                                                       aria-hidden="true"></span>手机</a></div>
    <div class="foot_nav"><a id="gotocate" href="javascript:;"><span class="glyphicon glyphicon-th-list btn-lg"
                                                                     aria-hidden="true"></span>分类</a></div>
    <div class="foot_nav"><a id="gototop" href="javascript:;"><span class="glyphicon glyphicon-circle-arrow-up btn-lg"
                                                                    aria-hidden="true"></span>顶部</a></div>
</nav>

<footer>
    <div class="copyright">
        <p>CopyRight 2019 All Right Reserved 日本肿瘤研究院株式会社&nbsp; <a href="javascript:;" target="_blank">网站地图</a></p>
        <p class="copyright_p">本站的目的是XXXX&nbsp;</p>
    </div>

</footer>

</body>
</html>
